R499.00
Oral sunscreen. All skin types.
Heliocare® Ultra Oral Capsules are proven to provide a clinically significant reduction in UV allergic skin reactions such as PLE; this is due to the unique and patented Fernblock™Photoimmunoprotection Technology. Fernblock™, an extract from a tropical fern, P. leucotomos is a key ingredient in the Heliocare® range. This patented technology was discovered and developed by leading Dermatologists Drs Fitzpatrick, Pathak and Gonzales and is recommended by Dermatologists across the USA and around the world as an oral supplement which is clinically proven to help skin protect itself against UV ageing and damage “from within”..
Oral sunscreen. All skin types.
Heliocare® Ultra Oral Capsules are proven to provide a clinically significant reduction in UV allergic skin reactions such as PLE; this is due to the unique and patented Fernblock™Photoimmunoprotection Technology. Fernblock™, an extract from a tropical fern, P. leucotomos is a key ingredient in the Heliocare® range. This patented technology was discovered and developed by leading Dermatologists Drs Fitzpatrick, Pathak and Gonzales and is recommended by Dermatologists across the USA and around the world as an oral supplement which is clinically proven to help skin protect itself against UV ageing and damage “from within”.
Weight | 0.4 kg |
---|---|
Dimensions | 6 × 6 × 15 cm |
Size | 30 capsules |
Skin Type | Acne, Combination, Dry & Dehydrated, Normal, Oily |
Key Ingredients | Fernblock®, Gluten-free, Lutein, Lycopen, Vitamin C |
Once daily in the morning.
Heliocare® Ultra Oral Capsules clearly show a skin-specific anti-oxidant activity, fibroblast and collagen protection, langerhan cell protection, DNA protection and repair and a clinically significant reduction in UV allergic skin reactions such as PLE.
Caccialanza et al (2007) demonstrated that Heliocare® Ultra Oral Capsules could help reduce different types of UV-induced skin reactions in patients who had previously been unresponsive to other treatments. 80% of the patients who completed the study showed an improvement in their condition with 31% showing a complete normalisation with no occurrences of skin reactions upon UV exposure.
In 2010, Tanew et al, investigated the effects of Heliocare® Ultra Oral Capsules on patients severely affected with PLE. 30 patients receiving Heliocare® Ultra Oral Capsules daily showed substantial reduction in the frequency of occurrence of PLE lesions following UVA and UVB exposure and also a significant delay in their formation.
Indications: People with sensitive skins. Post chemical peels or laser treatment. People with skin conditions requiring UVA or UVB radiation e.g.: psoriasis, porphyria Medications that increase a persons sensitivity to the sun. People who are prone to skin cancer.
Reviews
There are no reviews yet.